Article Versions Notes

Waldera-Lupa DM, Poschmann G, Kirchgaessler N, Etemad-Parishanzadeh O, Baberg F, Brocksieper M, Seidel S, Kowalski T, Brunn A, Haghikia A, et al. A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry. Cancers. 2020; 12(7):1732. https://doi.org/10.3390/cancers12071732

Waldera-Lupa, Daniel M., Gereon Poschmann, Nina Kirchgaessler, Omid Etemad-Parishanzadeh, Falk Baberg, Mareike Brocksieper, Sabine Seidel, Thomas Kowalski, Anna Brunn, Aiden Haghikia, and et al. 2020. "A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry" Cancers 12, no. 7: 1732. https://doi.org/10.3390/cancers12071732

Waldera-Lupa, D. M., Poschmann, G., Kirchgaessler, N., Etemad-Parishanzadeh, O., Baberg, F., Brocksieper, M., Seidel, S., Kowalski, T., Brunn, A., Haghikia, A., Gold, R., Stefanski, A., Deckert, M., Schlegel, U., & Stühler, K. (2020). A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry. Cancers, 12(7), 1732. https://doi.org/10.3390/cancers12071732